Pacer Advisors, Inc. Dexcom Inc Transaction History

Pacer Advisors, Inc.

$35.5 Billion
Q1 2025

A detailed history of Pacer Advisors, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Pacer Advisors, Inc. holds 39,387 shares of DXCM stock, worth $3.38 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

39,387

Previous 51,154 23.0%

Holding current value

$3.38 Million

Previous $3.98 Million 32.4%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	SELL	$67.74 - $90.75 $797,096 - $1.07 Million	-11,767 Reduced 23.0%	39,387 $2.69 Million
Q4 2024 Jan 22, 2025	SELL	$65.68 - $81.01 $156,187 - $192,641	-2,378 Reduced 4.44%	51,154 $3.98 Million
Q3 2024 Nov 12, 2024	BUY	$64.0 - $116.06 $269,632 - $488,960	4,213 Added 8.54%	53,532 $3.59 Million
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $532,907 - $678,513	4,831 Added 10.86%	49,319 $5.59 Million
Q1 2024 May 10, 2024	SELL	$114.22 - $140.1 $1.22 Million - $1.5 Million	-10,686 Reduced 19.37%	44,488 $6.17 Million
Q4 2023 Jan 16, 2024	BUY	$75.49 - $124.16 $306,187 - $503,592	4,056 Added 7.93%	55,174 $6.85 Million
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $3.46 Million - $5.55 Million	-40,258 Reduced 44.06%	51,118 $4.77 Million
Q2 2023 Jul 12, 2023	SELL	$112.47 - $130.98 $4.75 Million - $5.54 Million	-42,275 Reduced 31.63%	91,376 $11.7 Million
Q1 2023 May 02, 2023	BUY	$104.0 - $122.92 $12.6 Million - $14.9 Million	121,179 Added 971.61%	133,651 $15.5 Million
Q4 2022 Feb 06, 2023	SELL	$84.98 - $122.67 $10.8 Million - $15.5 Million	-126,637 Reduced 91.03%	12,472 $1.41 Million
Q3 2022 Oct 18, 2022	BUY	$76.35 - $94.18 $9.13 Million - $11.3 Million	119,636 Added 614.37%	139,109 $11.2 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $35,830 - $70,033	527 Added 2.78%	19,473 $1.45 Million
Q1 2022 Apr 05, 2022	BUY	$94.08 - $130.2 $799,774 - $1.11 Million	8,501 Added 81.39%	18,946 $9.69 Million
Q4 2021 Feb 03, 2022	BUY	$129.87 - $162.82 $148,831 - $186,591	1,146 Added 12.32%	10,445 $5.61 Million
Q3 2021 Oct 15, 2021	SELL	$106.71 - $143.18 $28,171 - $37,799	-264 Reduced 2.76%	9,299 $5.09 Million
Q2 2021 Jul 21, 2021	BUY	$80.99 - $107.93 $90,870 - $121,097	1,122 Added 13.29%	9,563 $4.08 Million
Q1 2021 Apr 05, 2021	SELL	$84.79 - $104.74 $38,155 - $47,133	-450 Reduced 5.06%	8,441 $3.03 Million
Q4 2020 Jan 20, 2021	SELL	$78.0 - $104.5 $427,674 - $572,973	-5,483 Reduced 38.15%	8,891 $3.29 Million
Q3 2020 Oct 19, 2020	SELL	$95.51 - $112.95 $91,785 - $108,544	-961 Reduced 6.27%	14,374 $5.93 Million
Q2 2020 Jul 29, 2020	BUY	$62.68 - $105.34 $961,197 - $1.62 Million	15,335 New	15,335 $6.22 Million
Q4 2017 Feb 14, 2018	SELL	$11.12 - $15.38 $137,854 - $190,665	-12,397 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$11.36 - $18.98 $140,829 - $235,295	12,397	12,397 $607,000

Others Institutions Holding DXCM

# of Institutions

1,082

Shares Held

362M

Call Options Held

5.4M

Put Options Held

4.3M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Dexcom Inc Transaction History